{"lastClose": 1.6799999475479126, "len": 466, "date": "2023-02-22", "alpha_1": -0.5354133896891747, "beta_1": 2.486017261221057, "drawup_1": 0.6999999674883763, "natr_1": 27.562806284995002, "sup_1": -0.4087301364854163, "res_1": 0.34325400640792525, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 52.91970728290847, "adx_1": 29.483659599756773, "drawdown_1": -0.6702820093482836, "stratHoldSharpe_1": -0.4683935874369408, "stratHoldAlpha_1": 250.59188009049575, "stratHoldDrawdown_1": -0.6084008044162359, "alpha_3mo": 0.0361475177847399, "beta_3mo": 2.6344380524617357, "drawup_3mo": 0.44078952940877514, "sharpe_3mo": -0.4332007494389485, "natr_3mo": 27.562806284995002, "sup_3mo": -0.0694444040378552, "res_3mo": 0.13492067603117167, "bullPattern_3mo": ["CLOSINGMARUBOZU", "LONGLINE"], "bearPattern_3mo": ["TASUKIGAP"], "rsi_3mo": 35.96490980405443, "adx_3mo": 28.907429955547066, "drawdown_3mo": -0.2694064008963667, "stratHoldSharpe_3mo": -0.5084372617480689, "stratHoldAlpha_3mo": 250.6236150315702, "stratHoldDrawdown_3mo": -0.2447004687583828, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Country": "United States", "Market Cap": 3439511374, "Name": "Ginkgo Bioworks Holdings Inc. Class A", "Sector": "Health Care", "IPO Year": 2021.0, "alpha%_1": 0.06860066987175467, "beta%_1": 0.9984678127629132, "drawup%_1": 0.653872468179283, "natr%_1": 1.0, "drawdown%_1": 0.06801221458587181, "stratHoldSharpe%_1": 0.19323359800271023, "stratHoldAlpha%_1": 0.035145961387885484, "stratHoldDrawdown%_1": 0.0725579669991021, "alpha%_3mo": 0.27312426400712103, "beta%_3mo": 0.9980265962118156, "drawup%_3mo": 0.8597832944374766, "sharpe%_3mo": 0.10047747714355632, "natr%_3mo": 1.0, "drawdown%_3mo": 0.06904870304021575, "stratHoldSharpe%_3mo": 0.24835940478789637, "stratHoldAlpha%_3mo": 0.1490044244925911, "stratHoldDrawdown%_3mo": 0.06906666163299638}